Your browser doesn't support javascript.
loading
Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients.
Tangedal, Solveig; Nielsen, Rune; Aanerud, Marianne; Persson, Louise J; Wiker, Harald G; Bakke, Per S; Hiemstra, Pieter S; Eagan, Tomas M.
Afiliação
  • Tangedal S; Dept. of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.
  • Nielsen R; Dept. of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway.
  • Aanerud M; Dept. of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.
  • Persson LJ; Dept. of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway.
  • Wiker HG; Dept. of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway.
  • Bakke PS; Dept. of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway.
  • Hiemstra PS; Dept. of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.
  • Eagan TM; Dept. of Microbiology, Haukeland University Hospital, Bergen, Norway.
PLoS One ; 14(9): e0222449, 2019.
Article em En | MEDLINE | ID: mdl-31527888
ABSTRACT

BACKGROUND:

Exacerbations of chronic obstructive pulmonary disease (COPD) are debilitating events and spur disease progression. Infectious causes are frequent; however, it is unknown to what extent exacerbations are caused by larger shifts in the airways' microbiota. The aim of the current study was to analyse the changes in microbial composition between stable state and during exacerbations, and the corresponding immune response.

METHODS:

The study sample included 36 COPD patients examined at stable state and exacerbation from the Bergen COPD Cohort and Exacerbations studies, and one patient who delivered sputum on 13 different occasions during the three-year study period. A physician examined the patients at all time points, and sputum induction was performed by stringent protocol. Only induced sputum samples were used in the current study, not spontaneously expectorated sputum. Sputum inflammatory markers (IL-6, IL-8, IL-18, IP-10, MIG, TNF-α) and antimicrobial peptides (AMPs, i.e. LL-37/hCAP-18, SLPI) were measured in supernatants, whereas target gene sequencing (16S rRNA) was performed on corresponding cell pellets. The microbiome bioinformatics platform QIIME2TM and the statistics environment R were applied for bioinformatics analyses.

RESULTS:

Levels of IP-10, MIG, TNF-α and AMPs were significantly different between the two disease states. Of 36 sample pairs, 24 had significant differences in the 12 most abundant genera between disease states. The diversity was significantly different in several individuals, but not when data was analysed on a group level. The one patient case study showed longitudinal dynamics in microbiota unrelated to disease state.

CONCLUSION:

Changes in the sputum microbiota with changing COPD disease states are common, and are accompanied by changes in inflammatory markers. However, the changes are highly individual and heterogeneous events.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Microbiota / Inflamação Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Noruega

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Microbiota / Inflamação Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Noruega